Based on the provided case involving Eli Lilly & Company and the state governments' resistance to sharing Medicaid patients' medical records, we need to assess the compliance with the HIPAA Privacy Rule.

### Assessment:
1. **HIPAA Regulation IDs and Content:**
   - The relevant HIPAA regulations mentioned in the case are 45 C.F.R. § 164.512(e)(1)® and 45 C.F.R. § 164.514(b)(2).
   - These regulations provide provisions for the disclosure of medical records in legal settings under certain conditions.

2. **Determination of Compliance:**
   - Considering the case of Lilly's request for access to Medicaid patients' medical records for legal defense, the states' resistance, and the legal nuances involved, we need to evaluate if the disclosure aligns with the HIPAA Privacy Rule.

3. **Compliance Assessment Outcome: Permit or Forbid:**
   - In this scenario, the disclosure of Medicaid patients' medical records for litigation purposes by the state Medicaid agencies appears to be permitted under the HIPAA Privacy Rule.
   - The regulations allow for the release of medical information for legal proceedings, subject to specified conditions such as de-identification and other safeguards.

### Conclusion:
Based on the analysis of the case details and the relevant HIPAA regulations, the disclosure of Medicaid patients' medical records, as requested by Lilly for legal defense purposes, is **permitted** under the HIPAA Privacy Rule. The regulations cited in the case provide a framework that allows for such disclosures under specific circumstances, ensuring a balance between privacy protection and the needs of legal proceedings.